Logo

TBRG

TruBridge, Inc.

TBRG

TruBridge, Inc. NASDAQ
$21.96 -2.44% (-0.55)

Market Cap $329.60 M
52w High $32.00
52w Low $17.71
Dividend Yield 0%
P/E 91.5
Volume 68.28K
Outstanding Shares 15.01M

Income Statement

Period Revenue Operating Expense Net Income Net Profit Margin Earnings Per Share EBITDA
Q3-2025 $86.106M $39.99M $5.602M 6.506% $0.37 $14.538M
Q2-2025 $85.729M $40.832M $2.58M 3.009% $0.17 $10.365M
Q1-2025 $87.208M $39.535M $459K 0.526% $0.031 $14.719M
Q4-2024 $90.84M $40.612M $-3.065M -3.374% $-0.39 $14.096M
Q3-2024 $83.83M $39.517M $-9.809M -11.701% $0.45 $8.03M

Balance Statement

Period Cash & Short-term Total Assets Total Liabilities Total Equity
Q3-2025 $19.92K $399.412K $219.054K $180.358K
Q2-2025 $12.279M $390.151M $216.978M $173.173M
Q1-2025 $10.124M $388.842M $220.334M $168.508M
Q4-2024 $12.324M $394.432M $225.737M $168.695M
Q3-2024 $8.586M $401.533M $228.886M $172.647M

Cash Flow Statement

Period Net Income Cash From Operations Cash From Investing Cash From Financing Net Change Free Cash Flow
Q3-2025 $5.602M $13.59M $-3.987M $-1.962M $7.641M $13.653M
Q2-2025 $2.58M $8.757M $-4.727M $-1.875M $2.155M $8.213M
Q1-2025 $459K $5.76M $-2.232M $-5.728M $-2.2M $1.426M
Q4-2024 $-3.065M $10.296M $-1.682M $-4.876M $3.738M $6.139M
Q3-2024 $-11.132M $10.109M $-5.313M $-3.919M $877K $4.796M

Five-Year Company Overview

Income Statement

Income Statement TruBridge’s revenue has inched up over the past few years, but not dramatically, suggesting steady rather than explosive growth. Profitability, however, has been bumpy. The company moved from modest profits earlier in the period to losses more recently, with operating results dipping into the red and then just barely returning to positive. This points to a business that is covering its basic costs but with very thin margins, leaving little room for error. The recent losses indicate restructuring, investment, or cost pressure that has not yet fully paid off in stronger earnings.


Balance Sheet

Balance Sheet The balance sheet looks stable in size but somewhat tight in flexibility. Total assets have been fairly flat, equity has slipped a bit from its peak, and debt has crept higher over time. Cash on hand appears quite limited, which reduces the company’s cushion against shocks and makes it more reliant on continued cash generation or external financing. Overall, TruBridge does not appear stretched to a breaking point, but it does not have an especially conservative or cash-rich balance sheet either, and leverage is a factor to watch.


Cash Flow

Cash Flow Cash generation is a relative bright spot compared with the income statement. The business has generally produced positive operating cash flow, although one recent year was essentially breakeven. After modest spending on capital investments, free cash flow has usually been positive but small. This suggests the core operations are capable of funding day‑to‑day needs, but there is not a large surplus for aggressive expansion, big acquisitions, or rapid debt reduction without additional funding or improved profitability.


Competitive Edge

Competitive Edge TruBridge holds a specialized position serving rural and community healthcare providers, a niche that larger generalist competitors often overlook or underserve. Its integrated bundle of revenue cycle, electronic health record, and patient engagement tools tends to make customers “stickier,” because switching out of a full suite can be disruptive and costly. The ability to offer revenue cycle services that work with any electronic health record system broadens its reach beyond its own installed base. At the same time, the company still faces pressure from bigger health IT players and from the financial strain many smaller hospitals face, which can limit customers’ ability to spend and make contract wins more competitive.


Innovation and R&D

Innovation and R&D Innovation is a clear focus, particularly around automation and artificial intelligence. Internal programs like the “Dream Factory,” the use of robotic process automation, predictive analytics, and machine learning, and the integration of Microsoft’s Dragon Copilot all point to an effort to make workflows faster and smarter for clients. The nTrust shared‑risk subscription model, offshore delivery capabilities in India, and specialized tools like the TruBridge Encoder further differentiate the offering. The opportunity is that these initiatives can improve margins and customer loyalty; the risk is execution—these investments must translate into sustained adoption and stronger financial performance in a competitive and fast‑moving tech landscape.


Summary

TruBridge is a niche healthcare technology and services provider with stable but slow revenue growth and uneven profitability. Its balance sheet is serviceable but not overly conservative, with rising debt and limited cash that leave less room for prolonged setbacks. Cash flow is generally positive but modest, which can support ongoing operations and gradual improvement but may constrain larger strategic moves without better earnings. Competitively, the company benefits from deep expertise in rural and community healthcare, a sticky integrated product suite, and flexible revenue cycle solutions, but it operates in a crowded and evolving market and serves financially stressed customers. On the innovation front, TruBridge appears active and forward‑leaning, especially in AI, automation, and creative commercial models. The key question going forward is whether these strategic and technological strengths can translate into more consistent profits and a stronger financial cushion over time.